Arbor Biotechnologies
Pre-clinicalAt Arbor® Biotech, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.
Founded
2016
Focus
CRISPRGenetics & Genomics
About
At Arbor® Biotech, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.
Funding History
2Total raised: $239M
Series A$215MTemasekApr 15, 2021
Seed$24MARCH Venture PartnersMay 15, 2018
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile